Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose oral T3 sulfate pharmacokinetics study in healthy adults
2011-000824-14Phase 2Completed
- Sponsor
- Bracco Group
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of triiodothyronine sulfate sodium in hypothyroidism (4 arms), sponsored by Bracco Group. Primary endpoint: Serum T3S levels. Started Sep 2011; status: completed.
02
Drugs
triiodothyronine sulfate sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on 2011-000824-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000824-14.